Bumex — Competitive Intelligence Brief

Bumex (BUMETANIDE) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Loop Diuretic [EPC]. Area: Immunology.

marketed Loop Diuretic [EPC] Solute carrier family 12 member 1 Immunology Small molecule

Target snapshot

Bumex (BUMETANIDE).

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Bumex TARGET	BUMETANIDE		marketed	Loop Diuretic [EPC]	Solute carrier family 12 member 1	1983-01-01
Torasemide	Torasemide	Medical University of Warsaw	marketed		Solute carrier family 12 member 1
Arelix	PIRETANIDE		marketed	piretanide	Solute carrier family 12 member 1
TORSEMIDE	TORSEMIDE		marketed	Loop Diuretic [EPC]	Na+/K+/2Cl- carrier system	1993-01-01
Edecrin	ETHACRYNIC ACID	Bausch Health	marketed	Loop Diuretic [EPC]	Glutathione S-transferase P	1967-01-01
Lasix	furosemide	Generic (originally Hoechst AG)	marketed	Loop Diuretic [EPC]	ATP-binding cassette sub-family G member 2, CDGSH iron-sulfur domain-containing protein 1, G-protein coupled receptor 35	1966-07-01
FUROSEMIDE	FUROSEMIDE		marketed	Loop Diuretic [EPC]		1966-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

• 2033-10-06 — TORSEMIDE · 10154963 · Formulation · US
• 2034-04-03 — Lasix · 9884039 · Method of Use · US
• 2034-04-03 — Lasix · 11433044 · Method of Use · US
• 2034-04-03 — Lasix · 12370168 · Formulation · US
• 2034-04-03 — Lasix · 10272064 · Formulation · US
• 2040-12-04 — Bumex · 11123319 · Formulation · US
• 2040-12-04 — Bumex · 11260038 · Method of Use · US
• 2040-12-04 — Bumex · 12329731 · Formulation · US

Sponsor landscape (Loop Diuretic [EPC] class)

1. · 3 drugs in this class
2. Bausch Health · 1 drug in this class
3. Generic (originally Hoechst AG) · 1 drug in this class
4. Johannes Grand · 1 drug in this class